Pricing

Log inSign up

Cara Therapeutics

25 people · 0 jobs
‌

Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Industries

Biotechnology

Headquarters

Stamford, United States

Employees

51-200

Links

Org chart

Christopher Posner
CEO, President & Director
Collapse
Ryan Maynard
Chief Financial Officer
Frédérique Menzaghi
Chief Scientific Officer, SVP Research & Development
Scott Terrillion
General Counsel, Secretary & Chief Compliance Officer
Eric Vandal
SVP, Commercial
Rene Barron
Executive Director, HR
Andrew Albright
Executive Director, Alliance Management And Chief Of Staff
Jo Goncalves
Chief Medical Officer
Ralph Vaccaro
Executive Director, Information Technology

Board & advisors

Martin Vogelbaum
Chairman
Jeffrey L. Ives
Director
Lisa von Moltke
Director
Helen M. Boudreau
Director

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies